Welcome to our dedicated page for Oppenheimer Hld news (Ticker: OPY), a resource for investors and traders seeking the latest updates and insights on Oppenheimer Hld stock.
Oppenheimer Holdings Inc. (NYSE: OPY) is a middle market investment bank and full service broker-dealer active in the investment banking and securities industry. Through its subsidiaries, including Oppenheimer & Co. Inc., the firm reports news on retail securities brokerage, institutional sales and trading, investment banking, equity and fixed income research, market-making, trust services, and investment advisory and asset management services.
The OPY news flow frequently includes quarterly earnings releases detailing segment results for Wealth Management and Capital Markets, trends in assets under management, and commentary from management on market conditions. Investors can follow updates on advisory and underwriting activity, equities and fixed income trading volumes, and changes in revenue components such as commissions, advisory fees, and bank deposit sweep income.
Company announcements also highlight capital actions and corporate events, such as the declaration of quarterly and special cash dividends on Class A non-voting and Class B voting common stock, as reported in press releases and related Form 8-K filings. In addition, Oppenheimer regularly reports on senior hires and team expansions across its platform, including appointments in Healthcare Equity Capital Markets, biotech research, public finance investment banking, cash equity sales and trading, and regional wealth management leadership.
Other OPY news items describe the evolution of the firm’s Custody and Prime Services (CAPS) platform and the expansion of its global credit and high yield and distressed businesses in the U.S., Europe, and Asia. For readers tracking OPY, this news page offers a centralized view of earnings updates, strategic hires, platform developments, and capital-related announcements drawn from company press releases and disclosures.
Oppenheimer (NYSE: OPY) announced on October 6, 2025 that James Yoo was named Managing Director in its Healthcare Equity Capital Markets Investment Banking Group.
The company states Mr. Yoo brings 27 years of industry experience and will focus on biotechnology equity capital markets, including PIPEs, follow-on offerings, CMPOs and registered direct transactions. According to the PR, Yoo previously served as Oppenheimer's Healthcare Specialist on the Sales & Trading desk since 2023 and held roles at Piper Sandler, Mizuho, and Nomura. Management comments in the release highlight Yoo's execution track record and biotech relationships as strengthening Oppenheimer's Healthcare ECM platform.
Oppenheimer (NYSE: OPY) has announced a significant expansion of its Custody and Prime Services (CAPS) platform to better serve small and mid-sized hedge funds, investment managers, and family offices. The expansion integrates the firm's Fixed Income custody business, transforming CAPS into a comprehensive multi-asset platform supporting global fixed income, equities, and listed options.
Originally launched in 2022, CAPS leverages Oppenheimer's self-clearing and custody infrastructure to provide high-touch services aligned with the firm's core strengths in research, capital markets access, and execution services. The company has also strengthened its team by adding senior talent in client services and expanding internal staff dedicated to CAPS business development.
Oppenheimer (NYSE: OPY) has significantly expanded its High Yield and Distressed Credit business with the addition of six senior professionals to its London office. The team, joining from Stifel, includes leadership positions in trading, sales, research, and business management.
The new London group will collaborate with Oppenheimer's existing high-yield teams in the U.S. and Hong Kong, creating a global credit platform focused on delivering cross-border coverage. This strategic expansion enhances the firm's ability to provide institutional clients with worldwide access to high-yield and distressed credit opportunities.
Oppenheimer (NYSE: OPY) has appointed David Wright as Managing Director and Co-Regional Manager for the Pacific Northwest, while promoting Mark Trafford to serve as co-leader of the region. Both executives will report to Ed Harrington, Executive Vice President and Head of Private Client Division.
Wright brings 25 years of wealth management experience, most recently serving as Senior VP and Seattle Market Director at D.A. Davidson Companies. Trafford, a 30-year industry veteran, has been with Oppenheimer for nearly a decade. The appointments reflect Oppenheimer's expansion strategy in the Pacific Northwest, including growth plans across Washington State and recent expansion into Lake Oswego, Oregon.
Oppenheimer Holdings (NYSE:OPY) reported strong Q2 2025 results with net income of $21.7 million ($2.06 per basic share), more than doubling from $10.3 million ($0.99 per share) in Q2 2024. Revenue increased 12.9% to $373.2 million, driven by improved performance across segments.
The Wealth Management division saw revenue rise 5.1% to $246.4 million, with assets under management reaching a record $52.8 billion. Capital Markets revenue surged 33.5% to $123.0 million, significantly reducing its pre-tax loss to $3.9 million from $21.8 million year-over-year.
The company maintained strong capital positions, with stockholders' equity reaching $896.9 million and declared a quarterly dividend of $0.18 per share. The effective tax rate improved to 32.7% from 35.3% in the prior year period.
Oppenheimer Holdings (NYSE: OPY) has announced the appointment of Jon Hudson as Managing Director and Co-Head of its Healthcare Services Investment Banking team. Hudson brings over 25 years of healthcare industry experience and will report to Michael Margolis, Head of Healthcare Investment Banking Group.
Hudson, who will operate from Miami and Atlanta offices, previously served as Managing Director at Truist Securities where he co-founded the Physician Services practice. His experience spans M&A advisory and capital markets, with a focus on provider and physician services sectors, as well as the payor landscape.
Oppenheimer Holdings (NYSE: OPY) reported strong Q1 2025 financial results with net income of $30.7 million ($2.93 basic EPS), up from $26.1 million ($2.50 EPS) in Q1 2024. Revenue increased 4.2% to $367.8 million.
The Wealth Management segment saw revenue rise 1.7% to $242.0 million, though pre-tax income declined 10.5%. Advisory fees grew 12.2% due to higher Assets Under Management (AUM) of $48.9 billion. Capital Markets revenue increased 10.0% to $123.3 million, reducing its pre-tax loss to $5.1 million from $6.7 million.
The company faces challenges from uncertain macroeconomic conditions, with concerns about recession risks, reduced consumer confidence, and market volatility affecting capital market activity. The Board declared a quarterly dividend of $0.18 per share, payable May 23, 2025.
Oppenheimer Holdings (NYSE: OPY) has strengthened its Technology Investment Banking Group with the appointment of Ranjot Singh as Managing Director. Singh, who will be based in New York and report to Robin Graham, Head of Technology Investment Banking, brings over 16 years of experience and has executed more than $90 billion in M&A transactions.
Singh's previous roles include Senior Managing Director at Guggenheim Securities Investment Bank, positions at Barclays Capital and Lehman Brothers, and most recently served as CFO at Tillman Networks. He holds degrees from Nanyang Technological University, National University of Singapore, and an MBA from Dartmouth's Tuck School of Business.
The appointment enhances Oppenheimer's Technology Investment Banking group, which now comprises 18 senior bankers with expertise across more than 10 technology sub-sectors.
Oppenheimer & Co (OPY) has announced a strategic integration with GBI (Global Bullion International), enabling its wealth management clients to invest in physical precious metals through GBI's platform. The integration, announced on March 19, 2025, allows Oppenheimer's clients to directly buy, sell, store, and take delivery of gold, silver, and other precious metals from their wealth management accounts.
The partnership aims to expand Oppenheimer's alternative investment offerings and provide clients with portfolio diversification options. The integration incorporates GBI's platform into Oppenheimer's existing wealth management services, offering a seamless investment experience for clients seeking exposure to uncorrelated tangible assets.
Oppenheimer Holdings (NYSE: OPY) has announced a significant expansion of its European investment banking team with four key hires in London. The new team, joining from Hannam & Partners, includes Ernest Bell as Managing Director of European Head of Public M&A and Wealth Management, Giles Fitzpatrick as Vice Chairman and Managing Director of European Investment Banking, Richard Clarke as Senior Advisor, and Lucia Sviatkova as Associate.
Bell brings extensive experience having advised on deals exceeding $25 billion in public market and wealth management transactions. The expansion aims to strengthen Oppenheimer's presence in UK wealth management and public M&A sectors, with the team reporting to Max Lami, CEO of Oppenheimer European business.
The strategic hires come as the UK wealth management industry undergoes significant transformation driven by intergenerational wealth transfer and technological advancements, leading to increased US-led investment and M&A activity.